Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid Diseases 1Pituitary Neoplasms 1Pituitary Diseases 1Hypothyroidism 1

Interventions

entinostat 1corticorelin ovine 1antineoplaston AS 2-1 1antineoplaston A10 1Thyrotropin-Releasing Hormone 1Dexamethasone 1Deamino Arginine Vasopressin 1Complementary Therapies 1Clinical Laboratory Techniques 1Calcium Dobesilate 1Biological Therapy 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Pituitary Neoplasms × Thyrotropin-Releasing Hormone × Clear all
NCT00054756 2018-08-08

Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
96 enrolled 6 charts
EndocrineHead & Neck

Hypothyroidism, Pituitary Diseases, Pituitary Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡